Aug. 28 at 3:42 PM
$SCNX [Again] The SP has been relatively stable over the last several months; however, the Company is making significant progress (IMO) with its business model. I have highlighted these in-detail here (below), but they include an extended liquidity position to cover NWC, Arbli revenue scaling, Rezenopy commercialization on established marketing/sales pathways, strong GM (97-98%), reducing operating/net losses (margin improvement), IP extensions on both products to 2041. There are no guarantees, but if/when the SP moves here, it should be significant from current levels
$0.35-0.45, consolidation pattern, multiplier.
